Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices.
D000661:Amphetamine / Q000737:chemistry / Q000493:pharmacokinetics* / Q000633:toxicity; D000697:Central Nervous System Stimulants / Q000737:chemistry / Q000493:pharmacokinetics* / Q000633:toxicity; D015198:Designer Drugs / Q000737:chemistry / Q000493:pharmacokinetics / Q000633:toxicity; D004347:Drug Interactions; D016903:Drug Monitoring / Q000379:methods; D006801:Humans; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000737:chemistry / Q000493:pharmacokinetics / Q000633:toxicity; D015813:Substance Abuse Detection / Q000379:methods
D000697:Central Nervous System Stimulants; D015198:Designer Drugs; D000661:Amphetamine; D018817:N-Methyl-3,4-methylenedioxyamphetamine